ABSTRACT: Nature's motors are complex and efficient systems, which are able to respond to many different stimuli present in the cell. Nanomotors for biomedical applications are designed to mimic nature's complexity; however, they usually lack biocompatibility and the ability to adapt to their environment. Polymeric vesicles can overcome these problems due to the soft and flexible nature of polymers. Herein we will highlight the recent progress and the crucial steps needed to fabricate active and adaptive motor systems for their use in biomedical applications and our approach to reach this goal. This includes the formation of active, asymmetric vesicles and the incorporation of a catalyst, together with their potential in biological applications and the challenges still to overcome.
INTRODUCTION
Biological motors, such as ribosomes, 1 kinesins, 2 and ATP synthase, 3 are essential natural machines that perform their functions with supreme efficiency. Many scientists have tried to understand and mimic these structures by creating various synthetic micro-and nanosized motors, in particular those that lead to translational motion. Combining structural design with motion has led to many successful constructs, such as molecular motors, 4−6 switches, 7 ratchets, 8 bimetallic nanorods, 9−13 Janus capsules, 14, 15 and shuttles. 16, 17 The specific requirements of each motor depend on their application and functional design, yet, asymmetry plays an important role in the design, together with the incorporation of a catalyst that can convert chemical energy into motion. To mimic biological motors, the system should be adaptive and made from soft and biodegradable materials. This ensures that the motor can feel its environment and respond accordingly, so that it is able to actively perform the task it was designed for. So far, the majority of research has focused on creating artificial motors that are based on metal catalysts or metal surfaces and are therefore not compatible for biomedical applications. The challenge is to design nanomotors made of soft materials, which are adaptive and fully biocompatible and/or biodegradable. Therefore, it is necessary to consider not only the structural design but also the construction approach.
The two main approaches for the formation of micro-and nanostructures are top-down and bottom-up, although, increasingly hybrid methods are used as well, which combine advantages of both methods. With the top-down approach, larger structures or patterns are reduced to nanoscale dimensions. The methods that are mostly used are subtractive and additive lithography techniques, such as etching, electrodeposition, and sputtering, or molding processes, such as PDMS printing. Fabrication using a top-down approach is straightforward and cheap; however, the scale up production is difficult to achieve and it faces size limitations when going for even smaller designs. The first nano-and micromotors have been created using these techniques. 18−21 The bottom-up approach starts with molecular building blocks that are used to build up the final structure, often involving synthesis or selfassembly. The bottom-up approach is more versatile in design and choice of materials. With this method the smallest structures can be made, for instance the well-known molecular motors from the Feringa group. 22−24 Lately, several examples of nanomotors are published that combine the top-down and bottom-up approach, such as the fabrication of ordered arrays of functional nanotubes, 25 directed self-assembly of polymers by patterned templates, 26 and layer-by-layer deposition to form multilayer Janus capsules. 27 However, limited examples exist of motors created solely by bottom-up approaches. 28, 29 Our lab has reported bottom-up self-assembly of micro-and nanomotors from different polymers. 17,30−33 The supramolecular approach to develop nanomotor carriers for biomedical applications is the main inspiration for our group. Designing soft, biocompatible carriers has a wide range of implications, not only from the applications point of view, but also from the perspective of mimicking and consequent understanding of such fascinating structures. In this Perspective, the supramolecular paths to form asymmetric morphologies are discussed that form the foundation of our self-propelling structures. In the following subsections, we focus on the development of asymmetric structures into nanomotors by incorporating a catalyst and their potentials for biomedical applications by showing their adaptive abilities, cellular uptake and release of drug molecules. Comprehensive reviews focused on nano-and micromotors and their applications, 34−36 molecular motors, 37, 38 and on nanoreactors 39−41 and will not be discussed here. Instead, we specifically focus on self-assembled polymeric motors and our approach from fabrication to application.
SHAPE
The first factor to consider while designing autonomous particles is their shape. Asymmetry, either in catalyst distribution or in shape, is required to obtain autonomous motion. Here we focus on the design of asymmetric shapes for our micro-and nanomotor.
Polymersomes are bilayered polymeric vesicles made from amphiphilic block copolymers comprising hydrophobic and hydrophilic covalently linked chains ( Figure 1A,B) . In aqueous media, these block copolymers spontaneously self-assemble into spherical vesicles ( Figure 1C) . 17, 30 Thereby, three different compartments are created; an inner aqueous lumen, a hydrophobic membrane and a hydrophilic outer surface. During polymersome formation, cargo can be captured inside the lumen, which is shielded from potentially unfavorable environments in biological settings. 30, 42 This allows the formation of nanocarriers or nanoreactors for various applications, such as drug delivery, 43 imaging 44 or mimics of life-like systems. 45 Polymersomes show increased stability and membrane integrity compared to liposomes, due to their relatively thick membrane and are therefore used as alternative carriers. 17, 32 While a thick membrane allows them to tolerate changes in the environment, their morphology can be reengineered and reshaped upon different stimuli. The shape transformation of spherical polymersomes in response to various external stimuli, such as pH, 46 ,47 osmotic pressure, 48, 49 temperature, 50 ,51 chemical composition of the membrane 52, 53 and magnetic fields 54, 55 has been studied. Yet, it is important to highlight that the polymersome properties, i.e., size, surface charge, rigidity, and permeability, depend on their building blocks. 56−58 For the hydrophilic part of the block copolymer often poly(ethylene glycol) (PEG) is implemented, due to its stealth-like behavior. Although PEG is not biodegradable, it is proven to be biocompatible. 59, 60 As hydrophobic block, various polymers have been used, 61−63 i.e., polybutadiene (PBD), 64 polystyrene (PS), 65 poly(ε-caprolactone) (PCL), 66 and polylactide (PLA), 67 depending on their application. For instance, polybutadiene has a glass transition temperature (T g ) below room temperature, which makes the polymersomes quite flexible and suitable for drug release. On the other hand, polystyrene has a high T g , which creates a rigid amorphous membrane when the organic solvent is removed, due to tight packing of the benzene rings ( Figure 1A) . 68 These characteristics are useful for shape transformation of polymersomes, as different (intermediate) morphologies can be obtained. However, neither polybutadiene nor polystyrene are biodegradable, so for biomedical applications alternatives are required. Polylactide is a good candidate, as it is biodegradable and has comparable properties to polystyrene, i.e., a relatively high T g and similar Hildebrand solubility parameters ( Figure  1B) .
Creating various shapes from spherical polymersomes is exciting and important for many different applications. Therefore, understanding the fundamentals of the shape transformations is key. Spherical polymersomes can deflate via two distinct pathways defining the final morphology; prolates (rod-like structures) or oblates (disc-like structures) 49 ( Figure 1D ). The out-of-equilibrium situations that forces spherical polymersomes to deflate into different morphological structures can be explained in terms of bending energy (eq 1). 49 ,69
In this equation k is the bending rigidity constant (which depends on material properties), C is the mean surface curvature, and C 0 stands for the spontaneous surface curvature. When an external stimulus is applied to a flexible membrane, a positive or negative surface curvature is induced, thereby influencing the bending energy. A positive bending energy will lead to the formation of prolate morphologies, whereas a negative bending energy leads to the formation of oblate morphologies. The hydrophilic and hydrophobic parts of the polymersome largely influence the surface charge, temperature sensitivity, rigidity and permeability and thereby affect the shape change process. 56−58 For example, introducing an osmotic shock to spherical poly(ethylene glycol)-b-poly(D,Llactide) (PEG-b-PDLLA) polymersomes allows shape transformation into elongated nanotubes (prolates), whereas poly(ethylene glycol)-polystyrene (PEG-b-PS) showed stomatocyte morphologies (oblates) under similar conditions. 48, 49 However, careful tuning of the conditions makes it possible to create nanorods and nanotubes of PEG-b-PS 49 or stomatocytes of PEG-b-PDLLA. 70 By adding high amounts of PEG (M w 2000) to spherical polymersomes it is even possible to create stomatocyte in stomatocyte structures. 71 The final shape is not only important for their function but also for their application and communication to the environment. For example, structures with high aspect ratio have more interaction sites, leading to enhanced particle uptake by cells through multivalency. 72 Polymersomes assembled from PEG-b-PS have a flexible and responsive bilayer membrane in the presence of plasticizing organic solvents and are rigid and nonresponsive in water due to the tightly packed glassy hydrophobic polystyrene blocks in their membranes. Once the plasticizing solvent is completely removed, the kinetically driven process of membrane folding stops due to vitrification of the membrane. The shape transformation can therefore also be stopped at any moment during the shape transformation process by adding excess of water, quenching the (intermediate) structures and forcing the system in a kinetically trapped state. 73 These properties enabled the shape transformation of spherical vesicles into bowl-shaped stomatocytes via disc morphologies by dialyzing against water ( Figure 1D ). 30 However, small amounts of organic solvents or additives in the sample leave the membrane slightly flexible and permeable, allowing solvent exchange from the inner lumen and outside environment. This can result in a metastable configuration, where the system slowly relaxes to a more stable configuration. 73 For instance, spherical PEG-PS polymersomes can deflate in a mixture of water and organic solvent to prolate structures and subsequently inflate back to spheres after multiple days. By adding 50% (v/v) water, a slight osmotic pressure is generated over the spherical polymersomes, causing an outflow of organic solvent. The polymersomes will form a prolate morphology to lower the osmotic pressure at the expense of the bending energy. When the organic solvent is not removed, it acts as plasticizer, allowing water to flow back in slowly, relieving the bending energy. This results in the inflation of the prolates to the more stable spherical polymersomes. 49 The method in which the organic solvent is removed completely, is named the "solvent switch" method, as the plasticizing solvent is switched for water, rigidifying the final polymersome morphology. Another approach is the "reverse addition" method, in which glassy stomatocytes are reversibly plasticized and made flexible when dialyzed in a mixture of organic solvent and water. 30 Depending on the time of exposure to the plasticizer, different morphologies are obtained, such as ellipsoids and kippah structures. 74 When the same reverse dialysis method was applied to rigid glassy polymersomes, stomatocyte morphologies were obtained with different sizes of their openings, depending on the time of dialysis and the mixture and composition of water and organic solvent. 42 The desired morphologies could also be quenched by vitrifying the membrane in water, allowing reshaping of existing polymersome morphologies. The drawback of this method, however, is the limited control in the size of the opening of the stomatocytes due to the increased flexibility of the membrane during the reverse dialysis. A third method was developed to provide a mild methodology for shape trans- formation in biological setting for encapsulation of proteins and enzymes. Large amounts of solvent can damage these complex structures, as will be discussed in later sections, thus the "solvent addition" method was introduced. 42 In this method, small amounts of solvent are added to spherical PEG-PS polymersomes to introduce shape transformation based on fast osmotic stress generation over the glassy PS membrane. Upon addition of less than 25% (v/v) of solvent, a shape transformation from spherical polymersomes to large opening stomatocytes was observed. Adding more aliquots led to a decrease of the stomatocyte neck size, to the extent that virtually closed stomatocytes were obtained. At any stage of this cycle, organic solvent could be removed and water could be added to capture the stomatocyte structure with controlled opening. The stomatocyte structure provides both asymmetry as well as a protected inner cavity, thus offering a lot of interesting possibilities, especially for nanomotors or nanoreactor applications.
Recently, we designed a micromotor to mimic the stomatocyte shape at the microscale. 33 Because such microsized particles are easier to visualize, we hoped to learn more about their behavior and correlate this to the nanoscale. Although this is a nice strategy to mimic the shape of the stomatocyte nanoparticles, the microparticle is made from a completely different material; a cross-linked gel. The formation of asymmetric particles is based on the phase separation of two polymeric solutions, which are poly(ethylene glycol)diacrylate (PEGDA) and dextran. In a microfluidic chip, a droplet-indroplet system is generated containing dextran in PEGDA in oil, which is the continuous phase and ensures emulsification of the PEGDA/dextran droplets. After collection from the chip, the PEGDA phase can be specifically polymerized due to the diacrylate functionality. The dextran phase is added as a template to provide the asymmetry in the particle. Upon polymerization of PEGDA, it will partly diffuse inside the gel and ensures a rough inner surface (Figure 2 ).
In the section below, the incorporation of a catalyst in the stomatocytes is described, including a metal catalyst, which decomposes hydrogen peroxide into water and propelling oxygen, and an enzyme couple catalyst that uses glucose as fuel.
AUTONOMOUS SYSTEMS
The first stomatocyte nanomotors were created by the encapsulation of platinum nanoparticles inside their cavity during the shape transformation via a process called "artificial endocytosis". 30 Interestingly, when large particles (100 nm) were used for encapsulation, size and shape of the stomatocyte cavity were accordingly affected due to a possible templating effect from the particle. Platinum is a known catalyst for the decomposition reaction of hydrogen peroxide into water and oxygen, which can escape through the opening of the stomatocytes, propelling it forward. The state-of-art design was conceptually an important milestone for developing new stomatocyte biohybrid motors, using enzymes instead of platinum as engines and utilizing biofuels instead of hydrogen peroxide for propulsion. For this purpose, the "solvent addition" methodology was developed to protect the enzymes from denaturation. Enzymes were first mixed with open neck stomatocytes and subsequently, the neck was closed by adding small amounts of organic solvent. This process led to the encapsulation of the enzymes while their denaturation was prevented, forming a hybrid polymeric supramolecular nanomotor ( Figure 3) . 42 We encapsulated the well-known enzyme cascade glucose oxidase (GOx) and catalase (Cat) in the stomatocytes to break down glucose. GOx catalyzes the oxidation of glucose to gluconolactone and H 2 O 2 , which is decomposed by Cat into water and propelling oxygen. The stomatocytes encapsulating both enzymes showed propulsion at biological relevant glucose concentration (5 mM) and continued moving in the presence of trypsin, a proteolytic enzyme known to inhibit enzymes activity.
ADAPTIVE NANOMOTORS
The next step, a far more challenging task, is to make adaptive systems that can interact and respond to their environment. Earlier attempts to achieve this adaptability by control over motion included disassembly of the complete system 75 and chemical inhibition of the catalytic process, 76 which led to the complete loss of motion without the possibility of restarting. Inhibition of the catalytic process involves adding more chemicals to the system, increasing complexity and decreasing 
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Perspective biocompatibility. Restarting the motor means getting rid of all the chemicals added for inhibition, which is time-consuming and in biological context not possible. With this in mind, finding a method to incorporate the ability for nanomotors to respond to its environment without altering its structure or its catalytic activity remains a challenging task. Here we discuss our attempts to make adaptive systems by gaining control over motion and directionality.
4.1. Control over Motion. Our strategy to gain control over motion is by incorporating stimuli responsive units onto the stomatocytes opening, which allows reversible opening and closing of the "molecular valve" upon, for example, a temperature stimulus. This will lead to a cut off of the fuel supply and thus stop the motor from moving autonomously. This motion-controlled system is based on the integration of a temperature-responsive poly(N-isopropylacrylamide) (PNI- PAM) brush onto the stomatocyte nanomotor surface that was grown onto the motor's surface using surface-initiated atom transfer radical polymerization (SI-ATRP). 77 PNIPAM is a temperature-responsive polymer with a lower critical solution temperature (LCST) of around 35°C. 78 Above this LCST, PNIPAM undergoes a transformation from hydrophilic to hydrophobic that leads to a collapsed, coiled state of the polymer, forming a hydrophobic layer on top of the stomatocyte opening. The hydrophobic layer prevents access of the fuel to the nanomotor cavity, thereby ceasing their propulsion ( Figure 4A ). Turning the motor "on" and "off" is completely reversible and does not affect the motion behavior significantly. PNIPAM functionalized nanomotors exhibit only slightly lower speeds than the nonfunctionalized nanomotors. This might be due to its increased size or decreased diffusion through the PNIPAM brush, which lowers the access of fuel inside the nanomotor even in its hydrophilic state. At higher temperatures, however, the propulsion diminished to a level that is almost as low as Brownian motion indicating successful functioning of the thermoresponsive brake system. 4.2. Control over Directionality. While achieving control over the motion is crucial for autonomous complex systems, control over directionality is of great significance especially for potential biomedical applications. An example is active drug delivery toward tumor cells that overproduce signaling molecules, i.e., hydrogen peroxide, that fuel the motion of the motor. 79 Excellent research has shown directional control of nano/micromotors by guiding them to the desired locations. Such a control is usually a response of the motors toward external stimulus such as temperature, 80 light, 81 concentration gradients, 82, 83 and magnetic fields.
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Again, nature is a great inspiration when it comes to directional movement. Bacteria, amoebas, and neutrophils sense substrate concentration gradients and accordingly navigate toward them. 85 Scientists have shown chemotaxis of various motors 82 or even single enzymes. 86 Chemotactic behavior toward high fuel concentration was also observed for the platinum loaded stomatocytes. 83 Different models were used to study the chemotactic behavior of platinum loaded stomatocytes, including static, dynamic and cell models. In the static and dynamic fluidic models, directionality toward higher fuel concentrations was observed even at concentrations as low as 0.5% hydrogen peroxide. The nanomotors showed chemotactic behavior along the fuel gradient as well as increased velocities at higher concentrations. Hydrogen peroxide excreting neutrophils were used as cell-model. Neutrophils in cell culture substrate were placed in the middle of a Petri dish containing a nanomotor solution. The nanomotors showed directional movement toward the hydrogen peroxide excreting cells. A decrease in directionality and speed was observed for positions further away from the fuel source ( Figure 4B ). It was hypothesized that the chemotactic directional control in movement was due to nanomotors developing higher speeds at higher fuel concentrations, thus traveling longer distances.
Another method to control motion is by the use of external magnetic fields, which allows a long-range directional control. Nickel loaded nanomotors are susceptible to magnetic fields due to their ferromagnetic behavior resulting in magnetotaxis. 87 Magnetic locomotion can be achieved by magnetic gradients while homogeneous fields can be used as navigation in the presence of fuel ( Figure 4C) . A gradient is established by using only one NdFeB magnet at the desired location, whereas homogeneous magnetic fields are applied by sandwiching the sample in between two magnets. Nanomotors encapsulating both platinum and nickel are catalytically powered in the presence of hydrogen peroxide as well as magnetic field and can be operated in dual propulsion mode. Adding hydrogen peroxide in combination with the magnetic gradient resulted in increased velocity and directionality. Magnetic locomotion is thus possible using magnetic gradients and can be enhanced by adding fuel. A collagen network loaded with HeLa cells was used as a tissue mimic to test transportation abilities of the nanomotors using magnetic locomotion. The nanomotors were guided through the gel network toward a cell via the magnetic gradient. Removing the homogeneous magnetic field resulted in dispersive movement.
4.3. Adaptive System with Feedback Control. The nanomotors based on platinum nanoparticles and the GOx/ Cat cascade were relatively simple nanomotor systems and an early attempt to increase biocompatibility. However, biological systems are using metabolic pathways, out-of-equilibrium enzymatic networks with integrated feedback loops, which allow adaptation in response to changes in the environment. We have implemented this bioinspired concept and incorporated an entire glycolysis inspired metabolic pathway inside the stomatocytes to generate adaptive nanomotors with sustained autonomous movement. 88 This system can sense and adapt to the chemical environment and the presence of available fuel.
An enzymatic reaction network that is able to convert naturally present substrates into molecular oxygen was rationally designed. This enzymatic network consists of four metabolic modules, working together for tunable and sustained output. The first "activation module" acts as activation and regulation of the enzyme cycles by the conversion of ATP. The next cycle is responsible for the generation of β-nicotinamide adenine dinucleotide (β-NADH), which is consumed in the third cycle to produce hydrogen peroxide. Finally, the last cycle containing Cat will decompose hydrogen peroxide into water and oxygen and is thus the motor of the system. This enzymatic reaction network was encapsulated in the cavity of PEG-PS stomatocytes and their motion was further analyzed in the presence of glucose as fuel. At 10 mM glucose, the motors speed output stayed constant even after 180 min, highlighting the ability of this network in sustaining its output through extended periods of time by regulating fuel consumption ( Figure 4D ). The network output was also tuned by changing ATP concentration, because ATP determines the concentration of β-NADH and thus the consequent hydrogen peroxide production. The capability of this enzymatic network to maintain a fixed motor speed output during glucose consumption and the possibility of tuning this output by controlling the speed of certain cycles in the network is unique and advantageous.
In this case, the protective element and the confinement effect of the stomatocyte nanomotor was highlighted by showing its functioning in complex media, human blood serum (HBS). HBS contains many different proteins and enzymes, among which is catalase. When hydrogen peroxide is not produced in the cavity, but in bulk, it is converted by free catalase present in the medium. As a result, the hydrogen peroxide concentration is lowered to such an extent that the entrapped catalase cannot induce any propulsion anymore. In HBS, motion of stomatocytes was maintained and was unaffected by the media. This is an important aspect when considering the use of this system in biological context. 
BIOMEDICAL APPLICATIONS
Many of the nanomotor designs have been developed with the idea of using them for biomedical applications, such as drug delivery, 15, 83 organelle mimics, 89−91 and cargo transporters in medical devices. 92, 93 One of the greatest challenge is, however, the realization of a nanometer scale transporter with controlled size, shape, and suitable design to facilitate these applications. In particular, the biodegradability and biocompatibility of the transporter as well as the available fuels in biological systems. Furthermore, the nanostructures should be able to capture cargo, transport and release it at the desired location, which desirably would be inside cells for drug delivery purposes. We already discussed the formation of biocompatible/degradable structures, catalysts and fuels. The next step is to translate this to biomedical applications, for which the motors should be able to release cargo and to actively find the desired location.
5.1. Release of Cargo. A hydrophilic cargo drug can be captured inside the hydrophilic core of the polymersomes, after which it can be transformed into a nanomotor carrying this cargo in the inner compartment. To be able to release this cargo, the nanomotor membrane should be degradable. This can be done by incorporating biodegradable building blocks such as PCL as hydrophobic part to make mixed PEG-PCL/ PEG-PS stomatocyte structures. Incorporation of up to 75% PEG-b-PCL maintained the stomatocyte morphology and did not affect the speed of the motor. 66 The PEG-b-PCL formed domains in the bilayer vesicle at percentages higher than 50% due to its semicrystallinity. This is advantageous, because PCL degrades at low pH, and resulted in the formation of large pores in the stomatocytes, which enabled release of cargo. Higher percentages of PCL showed increased release of cargo at pH 5 ( Figure 5A ). In vitro experiments showed that particles were taken up by HeLa cells and subsequently released their cargo as a response to the local low pH environment. The reference sample, consisting of nonbiodegradable PEG-PS nanomotors, did not release their cargo as can be seen by the presence of fluorescent spots instead of the homogeneously spread doxorubicin with the partly biodegradable system. 94 The same was observed for nanomotors having a disulfide bridge in between the hydrophilic and hydrophobic part of the polymers. 95 In the presence of reducing agent glutathione, which is also present in cells, the nanomotors cease their motion and release the drug upon complete destruction of their structure. In vitro, this resulted in a homogeneous diffusion of doxorubicin for the degradable motors, while the motors lacking the disulfide bridge were staying intact.
Another approach to release cargo is not by destroying the stomatocytes, but by changing their morphology, which leads to a release of cargo. The cargo is in this case not loaded in the inner polymersome core, but inside the stomatocyte cavity. Here, the cargo is in contact with the outer environment and can be released by opening the stomatocyte neck. Manipulation of the shape can be done by magnetic fields, because polystyrene is diamagnetic and it has a high anisotropic susceptibility in high magnetic fields. 54 When a magnetic field was applied to a stomatocyte solution containing a plasticizing organic solvent, a deformation was observed from an overall spherical stomatocyte structure to an elongated stomatocyte. Such a deformation is a result of the phenyl groups present in the PS backbone, which has a preference to align perpendicular to the applied magnetic field. Upon applying a magnetic field, first, the stomatocytes aligned because of the anisotropic distribution of the polymer orientations. Subsequently, the polymers itself aligned perpendicular to the magnetic field, inducing a change in morphology. This alignment resulted in a more stretched, elongated morphology and opened up the neck. The morphological change is completely reversible and dependent on the magnetic field strength, stronger fields result in a larger opening. This method allows for cargo to be captured and released at will and results in a more subtle release than the destruction of the whole system. However, the drawback of this system is the use of high magnetic fields.
5.3. Active Delivery. The next step is to obtain active delivery of the cargo to the desired location. Despite the disadvantages, the vast majority of drug delivery vehicles and their research is focused on passive delivery, which is slow and nonspecific. Enhanced uptake was already observed for nonfunctionalized active particles (nanomotors in the presence of fuel) compared to nonactive particles (nanomotors without fuel) due to a higher chance of interaction (Figure 5Bi-ii) . We functionalized stomatocyte nanomotors with a cell penetrating peptide, trans-activator of transcription (tat), 94 which ensured active uptake of our nanomotors into the cells. Cell experiments showed enhanced uptake of tat-functionalized nanomotors compared to nonfunctionalized nanomotors, due not only to their cell penetrating abilities but also to their associated motion (Figure 5Biii-iv) . Having both an active system as well as an active uptake mechanism will result in fast and efficient cell penetration. This approach will ensure uptake into cells, yet, reaching the diseased cells is a different problem. Until now, drug delivery is mostly passive utilizing the enhanced permeation and retention (EPR) effect. This effect is a result of the leaky blood vessels around a tumor which enhances the entry and accumulation of nutrients as well as drugs. 96 We investigated an enhanced EPR effect to reach cancer tissue by the exploitation of the nanomotors chemotactic behavior toward higher fuel concentrations, 97 as explained earlier. A model was made from a double-layer microslide consisting of an upper and bottom chamber separated by a porous membrane seeded with endothelial cells. The upper chamber was filled with nanomotors based on polymersomes having a platinum patch, while the bottom chamber was filled with either hydrogen peroxide or water. In the presence of hydrogen peroxide, the nanomotors accumulated twice as fast in the bottom chamber than in the presence of water. This shows that using motors as drug delivery system can result in an enhanced accumulation of the drug inside the tumor.
CONCLUSIONS AND FUTURE PERSPECTIVES
In this Perspective, we highlighted the crucial steps to fabricate active and adaptive locomotive systems for the use in biomedical applications and our approach to reach this goal. These include asymmetry, which is required for the formation of motors and can be obtained by the self-assembly of different amphiphilic block copolymers into different shapes, and the incorporation of enzymes or other catalysts that transforms passive vesicles into autonomous motors. We succeeded in gaining control over motion, directionality and speed and explored the possibilities of drug release and active targeting. We showed that self-assembled autonomous particles are not only capable of carrying a cargo but also move directionally in the presence of a gradient of signaling molecules produced by cells, transporting thus actively the cargo toward the cells producing fuel. Additionally the supramolecular nanomortors are interacting differently with cells compared with passive particles and are taking up faster. While blood provides good circulation of the nanocarriers at elevated speeds regardless if they are passive or active, it is the interstitial tissue where locomotive particles can help to facilitate crossing of the last barriers, which is a challenge in current delivery applications. Additionally, supramolecular nanomorors were demonstrated to facilitate enhanced EPR effect, spreading faster toward the signaling molecules compared to passive carriers.
Despite all the progress in the micro and nanomotor field during the past years, there are still challenges to overcome and questions to be answered, both regarding their mechanism of motion and movement in crowded environment but also toward their feasibility for applications in the biomedical field. This goal is coming slowly closer; however, most of the nanomotor systems are not at all or only partly biocompatible, utilizing toxic fuels for propulsion. The challenge is thus to construct fully biocompatible and biodegradable motors that can move directionally via chemotaxis in complex and crowded biological environments and at biological relevant fuel concentrations which are much lower than what has been studied so far. Another challenge is to have all these functionalities combined in one active delivery system while moving in biological fluids. Until now, most research has been done in water or buffer. However, bodily fluids have a complex composition of many different substituents that will affect motion but could also affect other functionalities such as targeting.
Another question that remains is a more fundamental one. What is the exact underlying mechanism of motion and how can we control the motion, directionality, and speed at the nanoscale in complex environments? This depends on different aspects of the motors, such as size and the materials it is made of. This is an experimentally difficult question when dealing with nanomotors, because most of the analysis techniques, such as light scattering, are indirect. This challenge makes it even more interesting to answer this question. When the mechanism of motion is clear and completely understood, we can more easily manipulate the system and this will help overcome challenges and reach goals that are still ahead. The recently published hydrogel micromotors from our group will be used for this goal, to gain more insight in the mechanism of motion and how to control this. ■ ABBREVIATIONS PEG, poly(ethylene glycol); PBD, polybutadiene; PS, polystyrene; PCL, poly(ε-caprolactone); PLA, polylactide; PDLLA, poly(D,L-lactide); ATRP, atom transfer radical polymerization; ROP, ring opening polymerization; PEGDA, poly(ethylene glycol) diacrylate; GOx, glucose oxidase; Cat, catalase; cryo-TEM, cryo-transmission electron microscopy; EDX, energy dispersive X-ray spectroscopy; cryo-SEM, cryo-scanning electron microscopy; PNIPAM, poly(N-isopropylacrylamide); SI-ATRP, surface-initiated atom transfer radical polymerization; LCST, lower critical solution temperature; β-NADH, β-nicotinamide adenine dinucleotide; HBS, human blood serum; tat, trans-activator of transcription; EPR, enhanced permeation and retention.
